Interim scan during prostate cancer therapy helps guide treatment
IMAGE: 68Ga-PSMA11 PET MIP images at baseline and after 2 cycles of 177Lu-PSMA radioligand therapy in a patients with mCRPC. view more Credit: Andrei Gafita, Matthias Eiber, TUM School of Medicine, Klinikum rechts der Isar, Munich, Germany. New prostate cancer research shows that adding an interim scan during therapy can help guide a patient’s treatment. Prostate-specific…